首页> 外文期刊>Thrombosis Research: An International Journal on Vascular Obstruction, Hemorrhage and Hemostasis >Local catheter-based delivery of antithrombotic or antiproliferative drugs: a new concept for prevention of restenosis.
【24h】

Local catheter-based delivery of antithrombotic or antiproliferative drugs: a new concept for prevention of restenosis.

机译:基于局部导管的抗血栓形成或抗增殖药物的递送:预防再狭窄的新概念。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Drug eluting stents have reduced the incidence of restenosis after percutaneous coronary interventions significantly, but cause concern about long term safety. Local drug delivery using special application catheters is an alternative approach for intracoronary pharmacotherapy. Besides the fact, that no problematic coating as drug carrier has to be used, a local delivery independent of the stent itself by using catheter techniques offers further advantages - such as the possibility to treat the whole vessel wall, stent edges and adjacent vessel segments and not only the area close to the stent struts. METHODS AND RESULTS: We have developed a new local catheter-based delivery system for local intracoronary pharmacotherapy. An antithrombotic as well as an antiproliferative therapy concept for prevention of restenosis are presented in the manuscript. Our data show that local drug delivery of platelet glycoprotein VI and paclitaxel were effective in the reduction of thrombus formation and neointima formation in experimental animal models. CONCLUSIONS: A combination of early antithrombotic and antiatherosclerotic mechanisms may be a realistic and effective approach to minimize postinterventional thromboischemic events and neointima formation. These results may contribute to an advanced and even combined local intracoronary pharmacotherapy in near future, independent of stent coatings.
机译:背景:药物洗脱支架在经皮冠状动脉干预明显减少了再狭窄后的发生率,但对长期安全造成了担忧。使用特殊应用导管的局部药物递送是颅内药理疗的替代方法。除此之外,没有使用作为药物载体的有问题的涂层,通过使用导管技术独立于支架本身的局部递送提供了进一步的优点 - 例如处理整个血管壁,支架边缘和相邻容器段的可能性不仅是靠近支架支柱的区域。方法和结果:我们开发了一种新的局部导管送达系统,用于局部肿瘤药物疗法。在手稿中介绍了抗血栓形成以及预防术止的抗激化治疗概念。我们的数据显示,血小板糖蛋白VI和紫杉醇的局部药物递送在实验动物模型中减少血栓形成和新内膜形成。结论:早期抗血栓形成和抗炎机制的组合可能是最大限度地有效的方法,以最大限度地减少初期性血栓性血肿事件和新内膜地层。这些结果可能导致在不久的将来的晚期甚至均匀的局部肿瘤药物治疗,与支架涂层无关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号